What's Going On With ZyVersa Stock?
What's Going On With ZyVersa Stock?
ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) shares are trading higher Monday after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for inhibiting ASC with IC 100 to potentially attenuate cardiac comorbidities in patients with Alzheimer's Disease.
週一，ZyVersa Therapeutics, Inc.（納斯達克股票代碼：ZVSA）股價走高，此前該公司宣佈在一份同行評審期刊上發表一篇科學論文，該論文強化了使用IC 100抑制ASC以減輕阿爾茨海默病患者心臟合併症的理由。
The Details:
細節：
Researchers from the University of Miami Miller School of Medicine and inventors of Inflammasome ASC Inhibitor IC 100, published a scientific paper in the peer-reviewed journal, "Frontiers in Molecular Neuroscience", highlighting how inflammasome-mediated inflammation in Alzheimer's disease can trigger inflammation in the heart.
邁阿密大學米勒醫學院的研究人員和Flammasome ASC抑制劑IC 100的發明者在同行評審期刊《分子神經科學前沿》上發表了一篇科學論文， 重點介紹了阿爾茨海默病中炎症體介導的炎症如何引發心臟發炎。
"This research reinforces the importance of attenuating activation of multiple types of inflammasomes that govern the inflammatory response in AD and mediating systemic inflammatory signals in EVs to control the spread of damaging inflammation to cardiovascular and other cells," commented Stephen C. Glover, ZyVersa's CEO.
ZyVersa首席執行官Stephen C. Glover評論說：“這項研究突顯了減弱控制AD炎症反應的多種類型炎症小體的激活以及介導電動汽車中的全身炎症信號以控制破壞性炎症向心血管和其他細胞擴散的重要性。”
"ZyVersa's Inflammasome ASC inhibitor IC 100 is designed to inhibit formation of multiple types of inflammasomes to attenuate initiation of the inflammatory cascade and to inhibit their associated ASC specks to reduce spread and perpetuation of damaging inflammation," Glover added.
格洛弗補充說：“ZyVersa的Inflamasome ASC抑制劑IC 100旨在抑制多種類型的炎症小體的形成，以減輕炎症級聯的啓動，並抑制其相關的ASC斑點，以減少破壞性炎症的擴散和延續。”
According to data from Benzinga Pro, ZyVersa effected a reverse stock split with a ratio of 1-for-20 last Friday leaving the stock with a float of less than 758,000 shares.
根據Benzinga Pro的數據，ZyVersa上週五進行了反向股票拆分，比率爲1比20，使該股的流通量不到75.8萬股。
Related News: What's Going On With ImmunityBio Stock?
相關新聞： ImmunityBio 股票怎麼了？
Is ZVSA A Good Stock To Buy?
ZVSA 是一隻值得買入的好股票嗎？
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like ZyVersa Therapeutics' page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
投資者在決定股票是否值得買入時可以做出一些決定。除了可以在Benzinga的報價頁面（例如ZyVersa Therapeutics的頁面）上找到的估值指標和價格走勢外，還有一些因素，例如公司是否每季度支付股息或購買大部分股票。
These are known as capital allocation programs. ZyVersa Therapeutics does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
這些被稱爲資本分配計劃。ZyVersa Therapeutics不支付股息，但顯然有幾種方法可以向股東返還價值。您可以隨時在Benzinga的股息日曆中搜索下一家即將派發股息的公司，並確定持有該公司股份可以獲得什麼樣的收益率。
For example, if you're looking to earn an annualized return of 9.75%, you'll need to buy a share of Allspring Inc Opps by the May 10. Once done, you can expect to receive a nominal payout of $0.05 on June 3.
例如，如果你想獲得9.75％的年化回報率，則需要在5月10日之前購買Allspring Inc Opps的股份。完成後，您預計將在6月3日收到0.05美元的名義補助金。
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on ZyVersa Therapeutics will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
回購計劃顯然是不同的，而且變化很大。公司可以批准回購計劃，並在回購獲得批准的時間內酌情購買股票。瀏覽ZyVersa Therapeutics的最新消息通常可以得出該公司最近是否批准了回購計劃。回購計劃通常作爲股價的支撐，作爲需求的支撐。
ZVSA Price Action: According to Benzinga Pro, ZyVersa shares are up 22.5% at $6.11 at the time of publication Monday.
ZVSA價格走勢：根據Benzinga Pro的數據，ZyVersa的股價在週一發佈時上漲了22.5％，至6.11美元。
Image: : Phoenix Locklear from Pixabay
圖片：來自 Pixabay 的菲尼克斯·洛克利爾
譯文內容由第三人軟體翻譯。